Autopsy report · NCT03906565

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

“The efficacy evaluation (based on current data) deviated too much from results of previous clinical trials. It's assumed that high dropout rate of subjects, mainly due to covid-19 epidemic in China in the past 3 years, is the main reason.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 30 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.

Sponsor type

Industry

Conditions

Advanced or Metastatic CRC

Interventions

utidelone injection

Participants

30 (planned, not actual)

Sites

5

Countries

China

Trials that died the same way

• Pedicle Osteotomy for Stenosis Trial
  “In light of the ongoing COVID-19 pandemic and its impact on clinical trials” (63% match in meaning)
• Study on the Safety and Efficacy of Meplazumab for Injection Patients COVID-19
  “Based on current epidemic situation in China, there is few Mild and Moderate COVID-19 patients.” (62% match in meaning)
• Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
  “the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.” (61% match in meaning)
• Peripheral Nerve Stimulation for Back
  “Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.” (61% match in meaning)
• A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
  “The study was terminated early due to low enrollment and missing efficacy assessment data due to missed visits related to COVID-19.” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.